Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide - Goodman, SG; Fitchett, D; Armstrong, PW (Circulation, 2003)
et al.